Grants from research to prevent blindness surpass $7.9 million in 2005

January 26, 2006

Research to Prevent Blindness (RPB), a New York-based foundation and the world's leading voluntary health organization supporting eye research, awarded 81 grants, totaling more than $7.9 million in 2005.

"RPB remains committed to fueling the vision research engine that we, in our earlier years, helped to build in departments of ophthalmology across the country," said Diane S. Swift, President, RPB. "Basic and clinical researchers, at every stage of their careers, continue to make significant inroads into the understanding, prevention, treatment and eventual cures of all diseases of the human visual system. Recent breakthroughs in uncovering the genetic origins and molecular mechanisms of vision loss give us all reason to hope that we can more effectively help the increasing number of people suffering from these conditions."

Across the nation, RPB-supported laboratories investigate the entire spectrum of eye disease, from cataracts, glaucoma, and diabetic retinopathy to macular degeneration, retinitis pigmentosa and eye movement disorders. The 2005 RPB awards include research grants to departments of ophthalmology at 46 medical schools throughout the United States, plus individual awards such as the Lew R. Wasserman Merit Award, Research Professorships, and Senior Scientific Investigator, Physician-Scientist and Career Development Awards. A total of 174 individual ophthalmic scientists received RPB grant support in 2005. A total of 54 departments of ophthalmology at U.S. medical schools are currently receiving RPB support.

Since it was founded in 1960, RPB has channeled more than $240 million to medical institutions throughout the United States. As a result, RPB has been identified with nearly every major breakthrough in eye research in that time, including the development of laser surgery now used to treat diabetic retinopathy, glaucoma, macular degeneration, myopia, retinal detachment and astigmatism.

RPB's comprehensive grants program operates with economy and efficiency. Historically, 81% of RPB expenditures have gone directly for eye research.

Research to Prevent Blindness

Related Glaucoma Articles from Brightsurf:

Monitoring glaucoma at home
Glaucoma is a chronic condition that affects cells at the back of the eye.

Study finds novel mechanism that may confer protection against glaucoma
A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection that promotes resistance to the elevated intraocular pressure associated with glaucoma.

AI-supported test for very early signs of glaucoma progression
A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial.

New method gives glaucoma researchers control over eye pressure
Neuroscientists have developed a new method that permits continuous regulation of eye pressure without damage, becoming the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.

Glaucoma care in prison inmates
Data fromĀ 82 prison inmates treated in a glaucoma clinic at an academic hospital were used in this observational study to report on how treatment and follow-up, including medication adherence, were are managed.

New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.

Air pollution linked to higher glaucoma risk
Living in a more polluted area is associated with a greater likelihood of having glaucoma, a debilitating eye condition that can cause blindness, finds a new UCL-led study in the UK.

Long-term statin use associated with lower glaucoma risk
A new study brings the connection between statin use and risk of glaucoma into sharper focus.

Health burden of glaucoma has risen worldwide
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.

UAlberta scientists first to pinpoint a cause of pigmentary glaucoma
An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition.

Read More: Glaucoma News and Glaucoma Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to